clopidogrel has been researched along with Shock, Septic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bauer, M; Claus, RA; Deigner, HP; Eisenhut, Y; Hamacher, J; Kohl, M; Lösche, W; Reichel, J; Winning, J | 1 |
Boettel, J; Breuel, H; Kabisch, B; Lösche, W; Otto, GP; Sossdorf, M; Winning, J | 1 |
2 other study(ies) available for clopidogrel and Shock, Septic
Article | Year |
---|---|
Anti-platelet drugs and outcome in severe infection: clinical impact and underlying mechanisms.
Topics: Adult; Aged; Animals; Cell Line; Clopidogrel; Female; Fibrin; Gene Expression Profiling; Hemodynamics; Humans; Infections; Intensive Care Units; Length of Stay; Leukocytes; Lung; Male; Mice; Mice, Inbred BALB C; Middle Aged; Oligonucleotide Array Sequence Analysis; Platelet Activation; Platelet Aggregation Inhibitors; Pneumonia; Retrospective Studies; Shock, Septic; Ticlopidine | 2009 |
Effects of low-dose acetylsalicylic acid and atherosclerotic vascular diseases on the outcome in patients with severe sepsis or septic shock.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atherosclerosis; Blood Coagulation; Clopidogrel; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Sepsis; Shock, Septic; Ticlopidine; Treatment Outcome | 2013 |